Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film

References

• Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311:1901–1911.
   PubMed Web of Science ®Google Scholar
• Negri L, Ferreras A, Iester M, Timolol 0. Timolol 0.1% in glaucomatous patients: efficacy, tolerance, and quality of life. J Ophthalmol 2019;2019:4146124–12.
   PubMed Web of Science ®Google Scholar
• Cantor LB. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag 2006;2:337–346.
   PubMedGoogle Scholar
• Anwar Z, Wellik SR, Galor A. Glaucoma therapy and ocular surface disease: current literature and recommendations. Curr Opin Ophthalmol 2013; 24:136–143.
   PubMed Web of Science ®Google Scholar
• Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma 2008;17:350–355.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Liang H, Hamard P, et al. The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways. Ophthalmology 2008;115:109–115.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Labbé A, Liang H, et al. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res 2010;29:312–334.
   PubMed Web of Science ®Google Scholar
• Potvin R, Makari S, Rapuano C. Tear film osmolarity and dry eye disease: a review of the literature. Clin Ophthalmol 2015;9:2039–2047.
   PubMed Web of Science ®Google Scholar
• Dogru M, Kojima T, Simsek C, et al. Potential role of oxidative stress in ocular surface inflammation and dry eye disease. Invest Ophthalmol Vis Sci 2018;59:DES163.
   PubMed Web of Science ®Google Scholar
• Ablamowicz AF, Nichols JJ. Concentrations of MUC16 and MUC5AC using three tear collection methods. Mol Vis 2017;23:529–537.
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996;49:1304–1313.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70–77.
   PubMed Web of Science ®Google Scholar
• Erel O. A new automated colorimetric method for measuring total oxidant status. Clin. Bioche 2005;38:1103–1111.
   PubMed Web of Science ®Google Scholar
• Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112–119.
   PubMed Web of Science ®Google Scholar
• Dartt DA, Willcox M. Complexity of the tear film: importance in homeostasis and dysfunction during disease. Exp Eye Res 2013;117:1–3.
   PubMed Web of Science ®Google Scholar
• Chen Y, Mehta G, Vasiliou V. Antioxidant defenses in the ocular surface. Ocul Surf 2009;7:176–185.
   PubMed Web of Science ®Google Scholar
• Koh S, Tung CI, Inoue Y, et al. Effects of tear film dynamics on quality of vision. Br J Ophthalmol 2018;102:1615–1620.
   PubMed Web of Science ®Google Scholar
• Valente C, Iester M, Corsi E, et al. Symptoms and signs of tear film dysfunction in glaucomatous patients. J Ocul Pharmacol Ther 2011;27:281–285.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Renard J, Nordmann J, et al. Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension. Eur J Ophthalmol 2013;23:47–54.
   Web of Science ®Google Scholar
• Aguayo BA, Yeung JY, Chan CC, et al. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opin Drug Metab Toxicol 2016;12:1279–1289.
   PubMed Web of Science ®Google Scholar
• Tu EY. Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives. Saudi J Ophthalmol 2014;28:182–187.
   PubMedGoogle Scholar
• Steven DW, Alaghband P, Lim KS. Preservatives in glaucoma medication. Br J Ophthalmol 2018;102:1497–1503.
   PubMedGoogle Scholar
• Jaenen N, Baudouin C, Pouliquen P, et al. Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 2007;3:341–349.
   Google Scholar
• Rasmussen CA, Kaufman PL, Kiland JA. Benzalkonium chloride and glaucoma. J Ocul Pharmacol Ther 2014;30:163–169.
   PubMed Web of Science ®Google Scholar
• Brasnu E, Brignole-Baudouin F, Riancho L, et al. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line. Curr Eye Res 2008; 33:303–312.
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang H, Wang C, et al. Genoprotective effect of hyaluronic acid against benzalkonium chloride-induced DNA damage in human corneal epithelial cells. Mol Vis 2011;17:3364–3370.
   PubMed Web of Science ®Google Scholar
• Lushchak VI. Free radicals, reactive oxygen species, oxidative stress and its classification. Chem Biol Interact 2014;224:164–175.
   PubMed Web of Science ®Google Scholar
• Sies H, Berndt C, Jones DP. Oxidative stress. Annu Rev Biochem 2017;86:715–748.
   PubMed Web of Science ®Google Scholar
• Seen S, Tong L. Dry eye disease and oxidative stress. Acta Ophthalmol 2017;96:412–420.
   Web of Science ®Google Scholar
• Sedlak L, Zych M, Wojnar W, et al. Effect of topical prostaglandin F2α analogs on selected oxidative stress parameters in the tear film. Medicina (Kaunas). 2019;55:366.
   PubMed Web of Science ®Google Scholar
• Izzotti A, Saccà SC, Di Marco B, et al. Antioxidant activity of timolol on endothelial cells and its relevance for glaucoma course. Eye (Lond) 2007;22:445–453.
   PubMed Web of Science ®Google Scholar
• Yu ZK, Chen YN, Aihara M, et al. Effects of β-adrenergic receptor antagonists on oxidative stress in purified rat retinal ganglion cells. Mol Vis 2007;13:833–839.
   PubMed Web of Science ®Google Scholar
• Piste P. Cysteine-master antioxidant. Int J Pharm Chem Biol Sci 2013;3:143–149.
   Google Scholar
• Reichmann D, Voth W, Jakob U. Maintaining a healthy proteome during oxidative stress. Mol Cell 2018;69:203–213.
   PubMed Web of Science ®Google Scholar
• Comini MA. Measurement and meaning of cellular thiol:disufhide redox status. Free Radic Res 2016;50:246–271.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med 2009;30:1–12.
   PubMed Web of Science ®Google Scholar
• Dickinson DA, Forman HJ. Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 2002;973:488–504.
   PubMed Web of Science ®Google Scholar
• Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59.
   PubMed Web of Science ®Google Scholar
• Grek CL, Zhang J, Manevich Y, et al. Causes and consequences of cysteine S-glutathionylation. J Biol Chem 2013;288:26497–26504.
   PubMed Web of Science ®Google Scholar
• Espinosa-Diez C, Miguel V, Mennerich D, et al. Antioxidant responses and cellular adjustments to oxidative stress. Redox Biol 2015;6:183–197.
   PubMed Web of Science ®Google Scholar
• Piwowar A. Zaawansowane produkty utleniania białek. Część I. Mechanizm powstawania, struktura i właściwości. [Advanced Oxidation Protein Products. Part I. Mechanism of the Formation, Characteristics and Property]. Pol Merkur Lek 2010;28:166–169.
   PubMedGoogle Scholar
• Di Simplicio P, Franconi F, Frosalí S, et al. Thiolation and nitrosation of cysteines in biological fluids and cells. Amino Acids 2003;25:323–339.
   PubMed Web of Science ®Google Scholar
• Baudouin C, Denoyer A, Desbenoit N, et al. In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American ophthalmological society thesis). Trans Am Ophthalmol Soc 2012;110:40–63.
   PubMedGoogle Scholar
• Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med 2018;54:287–293.
   Web of Science ®Google Scholar
• Wang MT, Murphy PJ, Blades KJ, et al. Comparison of non-invasive tear film stability measurement techniques. Clin Exp Optom 2017;101:13–17.
   PubMed Web of Science ®Google Scholar
• Herbaut A, Liang H, Denoyer A, et al. Tear film analysis and evaluation of optical quality: a review of the literature. J Fr Ophtalmol 2019;42:21–35.
   PubMed Web of Science ®Google Scholar
• Cejková J, Ardan T, Simonová Z, et al. Decreased expression of antioxidant enzymes in the conjunctival epithelium of dry eye (Sjögren’s Syndrome) and its possible contribution to the development of ocular surface oxidative injuries. Histol Histopathol 2008;23:1477–1483.
   PubMed Web of Science ®Google Scholar
• Corrales RM, Galarreta D, Herreras J, et al. Antioxidant enzyme mRNA expression in conjunctival epithelium of healthy human subjects. Can J Ophthalmol 2011;46:35–39.
   PubMed Web of Science ®Google Scholar
• Singh R. Impression cytology of the ocular surface. Br J Ophthalmol 2005;89:1655–1659.
   PubMed Web of Science ®Google Scholar
• Tong L, Thia Z-Z. Update on the role of impression cytology in ocular surface disease. Taiwan J Ophthalmol 2019;9:141.
   PubMedGoogle Scholar
• Maciejczyk M, Zalewska A, Ładny JR. Salivary antioxidant barrier, redox status, and oxidative damage to proteins and lipids in healthy children, adults, and the elderly. Oxid Med Cell Longev 2019;2019:4393460
   PubMed Web of Science ®Google Scholar